BayScribe Announces Availability of Structured, Coded Data with CDA Output

Share Article

BayScribe announced several key relationships and enhancements to the BayScribe Clinical Documentation System (CDS) today including the ability to offer coded data via C32 output through its partnership with Intelligent Medical Objects®

BayScribe’s vision of producing a codified transcribed document is critical in meeting the efficiencies and requirements for Meaningful Use and Core Measurement reporting

From BayScribe’s newest office in Charlotte, NC, BayScribe announced several key relationships and enhancements to the BayScribe Clinical Documentation System (CDS) today including the ability to offer coded data via C32 output through its partnership with Intelligent Medical Objects® (IMO®). IMO is the leader in clinical interface terminology and will manage all terminology term changes and updates for BayScribe. This partnership provides the addition of billing and reporting codes to BayScribe documents, which will provide users of the BayScribe Care Team Dashboard easy access to information to improve the timeliness of document turnaround and the quality of patient care across a healthcare organization.

Steve Bonney, Vice President of Business Development at BayScribe made the announcement. “The future of the Clinical Narrative is brighter today. The ability for physicians to document patient encounters through the use of traditional methods like dictation and handwriting took a leap forward with our integration with IMO.” Through this strategic relationship with IMO, BayScribe reinforces its position as the leader in providing innovative ways to meet the clinical documentation needs in this challenging and advancing healthcare information technology (HIT) environment.

The partnership with IMO brings a new solution not previously available in the clinical documentation market that supports an organization’s need to expand the accessibility of discreet data within a patient’s medical record. Melinda Watman, VP of Strategic Partnerships at IMO stated, “BayScribe’s vision of producing a codified transcribed document is critical in meeting the efficiencies and requirements for Meaningful Use and Core Measurement reporting. Healthcare organizations are able to capture the coded data without imposing workflow changes on clinicians. This is essential for the adoption of new technology and is a win-win for all involved: transcriptionists, HIM departments, clinicians and organizations.”

The final piece of the unstructured documentation puzzle is the generation of a C32 CDA-formatted document (Clinical Document Architecture). The CDA is the de facto standard for exchanging Meaningful Use data with EHRs and, with the addition of the coded data from IMO, BayScribe expects to be the first Clinical Documentation System to generate Level-3 C32 output. IMO-coded documents deliver guaranteed billable ICD-9-CM codes as well as SNOMED, CPT, RxNORM, LOINC, HCPCS and other coding vocabularies. Additionally, through IMO, BayScribe documents will have seamless integration of ICD-10-CM codes available October 2011, two full years ahead of the mandated switchover date. “IMO is committed to offer vocabulary-enabled services to help our partners preserve the clinical intent and comply with their mandatory regulatory coding requirements,” stated Dr. Frank Naeymi-Rad, CEO of IMO.

The partnership with IMO further strengthens BayScribe’s already superior document production. In addition to IMO coding, BayScribe was already producing documents using Natural Language Processing (NLP) through the use of MedLEE, the Columbia University School of Medicine NLP engine, making it one of the first CDS to employ NLP. “The implementation of MedLEE is second to none,” commented Kyle Silvestro, noted NLP industry-expert and recently appointed EVP of HITEKS. Mr. Silvestro continued, “with the addition of IMO integration, BayScribe has made itself the strategic frontrunner in the evolving clinical documentation market.”

Facilities are struggling with how to capture as much structured documentation as possible to produce the required Core Measurements and Meaningful Use reporting. Clinicians want to maintain their current workflow methods while preserving the clinical intent of their captured words, including dictation and handwriting. BayScribe provides the solution to these challenges with the integration of Rover INK, NLP, IMO and C32 into the CDS – termed ‘The CURE’.

About BayScribe:
Established in 1999, BayScribe provides Clinical Documentation Solutions – Dictation, Digital Ink, Speech Recognition, Transcription, Structured/Encoded Data extraction & Document Distribution – for anywhere, anytime access of Clinical Reports with unparalleled performance and reliability. Every month, more than one hundred thousand clinicians in over 400 healthcare facilities rely on the BayScribe platform.

For more information visit the company website at: http://www.BayScribe.com. BayScribe, Inc. | 10800 Sikes Place, Suite 300 | Charlotte, NC 28277 T: 888-801-0106 - info(at)bayscribe(dot)com .

About IMO:
Intelligent Medical Objects® (IMO®) delivers a comprehensive suite of integrated, clinician-friendly medical vocabulary solutions that enable healthcare organizations to improve patient documentation, streamline workflow, coordinate care and increase revenue. IMO’s leading Clinical Interface Terminology products, including IMO Problem ÍITЙand IMO Procedure ÍITЙ, provide seamless mapping of diagnostic terminologies to billing codes and medical concepts, enhancing decision support, research, patient education, and financial operations. For more information, see http://www.e-imo.com.

© 2010 Intelligent Medical Objects, Inc. All rights reserved. Intelligent Medical Objects, Inc., Intelligent Medical Objects and IMO are registered trademarks. IMO Problem IT and IMO Procedure IT are trademarks of Intelligent Medical Objects, Inc. Other product or company names are or may be trademarks or registered trademarks of their respective companies.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Steve Bonney
Visit website